These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9349538)

  • 1. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite.
    Crow JP; Sampson JB; Zhuang Y; Thompson JA; Beckman JS
    J Neurochem; 1997 Nov; 69(5):1936-44. PubMed ID: 9349538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen peroxide damages the zinc-binding site of zinc-deficient Cu,Zn superoxide dismutase.
    Sampson JB; Beckman JS
    Arch Biochem Biophys; 2001 Aug; 392(1):8-13. PubMed ID: 11469788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L.
    Crow JP; Ye YZ; Strong M; Kirk M; Barnes S; Beckman JS
    J Neurochem; 1997 Nov; 69(5):1945-53. PubMed ID: 9349539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
    Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS.
    Roberts BR; Tainer JA; Getzoff ED; Malencik DA; Anderson SR; Bomben VC; Meyers KR; Karplus PA; Beckman JS
    J Mol Biol; 2007 Nov; 373(4):877-90. PubMed ID: 17888947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase.
    Estévez AG; Crow JP; Sampson JB; Reiter C; Zhuang Y; Richardson GJ; Tarpey MM; Barbeito L; Beckman JS
    Science; 1999 Dec; 286(5449):2498-500. PubMed ID: 10617463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu,Zn-superoxide dismutase increases toxicity of mutant and zinc-deficient superoxide dismutase by enhancing protein stability.
    Garner MA; Ricart KC; Roberts BR; Bomben VC; Basso M; Ye Y; Sahawneh J; Franco MC; Beckman JS; Estévez AG
    J Biol Chem; 2010 Oct; 285(44):33885-97. PubMed ID: 20663894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
    Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
    Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of ALS-linked SOD1 mutants.
    Williamson TL; Corson LB; Huang L; Burlingame A; Liu J; Bruijn LI; Cleveland DW
    Science; 2000 Apr; 288(5465):399. PubMed ID: 10798964
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetic stability of Cu/Zn superoxide dismutase is dependent on its metal ligands: implications for ALS.
    Lynch SM; Boswell SA; Colón W
    Biochemistry; 2004 Dec; 43(51):16525-31. PubMed ID: 15610047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.
    Yim MB; Kang JH; Yim HS; Kwak HS; Chock PB; Stadtman ER
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5709-14. PubMed ID: 8650157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of copper ions from the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants.
    Eum WS; Kang JH
    Mol Cells; 1999 Feb; 9(1):110-4. PubMed ID: 10102580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc and copper in the pathogenesis of amyotrophic lateral sclerosis.
    Elliott JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1169-85. PubMed ID: 11474839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein.
    Lyons TJ; Liu H; Goto JJ; Nersissian A; Roe JA; Graden JA; Café C; Ellerby LM; Bredesen DE; Gralla EB; Valentine JS
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12240-4. PubMed ID: 8901564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational studies of the metal-binding site of the wild-type and the H46R mutant of the copper, zinc superoxide dismutase.
    Mera-Adasme R; Mendizábal F; Gonzalez M; Miranda-Rojas S; Olea-Azar C; Sundholm D
    Inorg Chem; 2012 May; 51(10):5561-8. PubMed ID: 22545761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation of ALS mutant superoxide dismutase expressed in Escherichia coli.
    Leinweber B; Barofsky E; Barofsky DF; Ermilov V; Nylin K; Beckman JS
    Free Radic Biol Med; 2004 Apr; 36(7):911-8. PubMed ID: 15019975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis.
    Trumbull KA; Beckman JS
    Antioxid Redox Signal; 2009 Jul; 11(7):1627-39. PubMed ID: 19309264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients.
    Marklund SL; Andersen PM; Forsgren L; Nilsson P; Ohlsson PI; Wikander G; Oberg A
    J Neurochem; 1997 Aug; 69(2):675-81. PubMed ID: 9231727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis.
    Orrell RW; Habgood JJ; Gardiner I; King AW; Bowe FA; Hallewell RA; Marklund SL; Greenwood J; Lane RJ; deBelleroche J
    Neurology; 1997 Mar; 48(3):746-51. PubMed ID: 9065559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin.
    Volkel H; Scholz M; Link J; Selzle M; Werner P; Tunnemann R; Jung G; Ludolph AC; Reuter A
    FEBS Lett; 2001 Aug; 503(2-3):201-5. PubMed ID: 11513882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.